 | | 78M | | Name: | (2S)-2,3-DIHYDROXYPROPYL(7Z)-PENTADEC-7-ENOATE | | Formula: | C18 H34 O4 | | SMILES: | O=C(OCC(O)CO)CCCCCC=C/CCCCCCC | | InChi: | InChI=1S/C18H34O4/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-18(21)22-16-17(20)15-19/h8-9,17,19-20H,2-7,10-16H2,1H3/b9-8-/t17-/m0/s1 | | Synonyms: | 7.8 MONOACYLGLYCEROL | | Definition date: | 2012-01-19 | | Last modified: | 2021-03-01 | | Release date: | 2013-02-01 | | Identifier: | (2S)-2,3-dihydroxypropyl (7Z)-pentadec-7-enoate |
|
 | | LFA | | Name: | EICOSANE | | Formula: | C20 H42 | | SMILES: | C(CCCCCCCCCCCCCCCCC)CC | | InChi: | InChI=1S/C20H42/c1-3-5-7-9-11-13-15-17-19-20-18-16-14-12-10-8-6-4-2/h3-20H2,1-2H3 | | Synonyms: | LIPID FRAGMENT | | Definition date: | 2003-11-19 | | Last modified: | 2021-03-01 | | Identifier: | icosane |
|
 | | 78N | | Name: | (2R)-2,3-DIHYDROXYPROPYL(7Z)-PENTADEC-7-ENOATE | | Formula: | C18 H34 O4 | | SMILES: | O=C(OCC(O)CO)CCCCCC=C/CCCCCCC | | InChi: | InChI=1S/C18H34O4/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-18(21)22-16-17(20)15-19/h8-9,17,19-20H,2-7,10-16H2,1H3/b9-8-/t17-/m1/s1 | | Synonyms: | 7.8 MONOACYLGLYCEROL (2R) | | Definition date: | 2012-01-19 | | Last modified: | 2021-03-01 | | Release date: | 2013-02-01 | | Identifier: | (2R)-2,3-dihydroxypropyl (7Z)-pentadec-7-enoate |
|
 | | 78P | | Name: | (2R)-2-(7-carbamoyl-1H-benzimidazol-2-yl)-2-methylpyrrolidinium | | Formula: | C13 H16 N4 O | | SMILES: | O=C(N)c3c1c(nc(n1)C2(NCCC2)C)ccc3 | | InChi: | InChI=1S/C13H16N4O/c1-13(6-3-7-15-13)12-16-9-5-2-4-8(11(14)18)10(9)17-12/h2,4-5,15H,3,6-7H2,1H3,(H2,14,18)(H,16,17)/t13-/m1/s1 | | Synonyms: | Veliparib | | Definition date: | 2007-10-09 | | Last modified: | 2021-03-01 | | Identifier: | 2-[(2R)-2-methylpyrrolidin-2-yl]-1H-benzimidazole-7-carboxamide |
|
 | | 791 | | Name: | 2-PHENYLMALONIC ACID | | Formula: | C9 H8 O4 | | SMILES: | O=C(O)C(C(=O)O)c1ccccc1 | | InChi: | InChI=1S/C9H8O4/c10-8(11)7(9(12)13)6-4-2-1-3-5-6/h1-5,7H,(H,10,11)(H,12,13) | | Synonyms: | RU78191 | | Definition date: | 2003-06-20 | | Last modified: | 2021-03-01 | | Identifier: | phenylpropanedioic acid |
|
 | | 799 | | Name: | 2-methyl-2-(4-{2-[3-methyl-1-(propan-2-yl)-1H-1,2,4-triazol-5-yl]-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepin-9-yl}-1H-pyrazol-1-yl)propanamide | | Formula: | C24 H28 N8 O2 | | SMILES: | C(N)(C(C)(C)n5cc(c1cc2c(cc1)c3n(CCO2)cc(n3)c4nc(C)nn4C(C)C)cn5)=O | | InChi: | InChI=1S/C24H28N8O2/c1-14(2)32-22(27-15(3)29-32)19-13-30-8-9-34-20-10-16(6-7-18(20)21(30)28-19)17-11-26-31(12-17)24(4,5)23(25)33/h6-7,10-14H,8-9H2,1-5H3,(H2,25,33) | | Synonyms: | taselisib | | Definition date: | 2016-09-13 | | Last modified: | 2021-03-01 | | Release date: | 2017-01-11 | | Identifier: | 2-methyl-2-(4-{2-[3-methyl-1-(propan-2-yl)-1H-1,2,4-triazol-5-yl]-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepin-9-yl}-1H-pyrazol-1-yl)propanamide |
|
 | | 79A | | Name: | 3-{[(1S)-2,2-difluoro-1-hydroxy-7-(methylsulfonyl)-2,3-dihydro-1H-inden-4-yl]oxy}-5-fluorobenzonitrile | | Formula: | C17 H12 F3 N O4 S | | SMILES: | N#Cc1cc(cc(c1)F)Oc2ccc(c3c2CC(C3O)(F)F)S(C)(=O)=O | | InChi: | InChI=1S/C17H12F3NO4S/c1-26(23,24)14-3-2-13(12-7-17(19,20)16(22)15(12)14)25-11-5-9(8-21)4-10(18)6-11/h2-6,16,22H,7H2,1H3/t16-/m0/s1 | | Synonyms: | PT2385 | | Definition date: | 2016-09-14 | | Last modified: | 2021-03-01 | | Release date: | 2016-09-21 | | Identifier: | 3-{[(1S)-2,2-difluoro-1-hydroxy-7-(methylsulfonyl)-2,3-dihydro-1H-inden-4-yl]oxy}-5-fluorobenzonitrile |
|
 | | LFX | | Name: | (3S)-9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid | | Formula: | C18 H20 F N3 O4 | | SMILES: | O=C(O)C=1C(=O)c4c2N(C=1)C(COc2c(N3CCN(C)CC3)c(F)c4)C | | InChi: | InChI=1S/C18H20FN3O4/c1-10-9-26-17-14-11(16(23)12(18(24)25)8-22(10)14)7-13(19)15(17)21-5-3-20(2)4-6-21/h7-8,10H,3-6,9H2,1-2H3,(H,24,25)/t10-/m0/s1 | | Synonyms: | Levofloxacin | | Definition date: | 2009-10-20 | | Last modified: | 2021-03-01 | | Identifier: | (3S)-9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid |
|
 | | LG5 | | Name: | 1-METHYL-1,6-DIHYDROPYRIDIN-3-AMINE | | Formula: | C6 H10 N2 | | SMILES: | NC=1C=CCN(C=1)C | | InChi: | InChI=1S/C6H10N2/c1-8-4-2-3-6(7)5-8/h2-3,5H,4,7H2,1H3 | | Synonyms: | 1-METHYL-1-LAMBDA-5-PYRIDIN-3-YL-AMINE | | Definition date: | 2005-11-10 | | Last modified: | 2021-03-01 | | Identifier: | 1-methyl-1,6-dihydropyridin-3-amine |
|
 | | LG9 | | Name: | (1R,2R,3R,6R,7R,7AR)-3,7-BIS(HYDROXYMETHYL)HEXAHYDRO-1H-PYRROLIZINE-1,2,6-TRIOL | | Formula: | C9 H17 N O5 | | SMILES: | OC2C(C1N(C(C(O)C1O)CO)C2)CO | | InChi: | InChI=1S/C9H17NO5/c11-2-4-6(13)1-10-5(3-12)8(14)9(15)7(4)10/h4-9,11-15H,1-3H2/t4-,5-,6+,7-,8-,9-/m1/s1 | | Synonyms: | CASUARINE ANALOGUE | | Definition date: | 2009-11-17 | | Last modified: | 2021-03-01 | | Identifier: | (1R,2R,3R,6R,7R,7aR)-3,7-bis(hydroxymethyl)hexahydro-1H-pyrrolizine-1,2,6-triol |
|
 | | LGN | | Name: | N-[(2S,3R,4E)-1-{[alpha-D-galactopyranosyl-(1->3)-beta-D-galactopyranosyl-(1->4)-beta-D-glucopyranosyl]oxy}-3-hydroxyoctadec-4-en-2-yl]hexacosanamide | | Formula: | C62 H117 N O18 | | SMILES: | O=C(NC(COC3OC(C(OC2OC(CO)C(O)C(OC1OC(CO)C(O)C(O)C1O)C2O)C(O)C3O)CO)C(O)/C=C/CCCCCCCCCCCCC)CCCCCCCCCCCCCCCCCCCCCCCCC | | InChi: | InChI=1S/C62H117NO18/c1-3-5-7-9-11-13-15-17-18-19-20-21-22-23-24-25-26-28-30-32-34-36-38-40-50(68)63-45(46(67)39-37-35-33-31-29-27-16-14-12-10-8-6-4-2)44-76-60-56(74)54(72)58(49(43-66)79-60)80-62-57(75)59(52(70)48(42-65)78-62)81-61-55(73)53(71)51(69)47(41-64)77-61/h37,39,45-49,51-62,64-67,69-75H,3-36,38,40-44H2,1-2H3,(H,63,68)/b39-37+/t45-,46+,47+,48+,49+,51-,52-,53-,54+,55+,56+,57+,58+,59-,60+,61+,62-/m0/s1 | | Synonyms: | Isoglobotrihexosylceramide | | Definition date: | 2011-05-13 | | Last modified: | 2021-03-01 | | Identifier: | N-[(2S,3R,4E)-1-{[alpha-D-galactopyranosyl-(1->3)-beta-D-galactopyranosyl-(1->4)-beta-D-glucopyranosyl]oxy}-3-hydroxyoctadec-4-en-2-yl]hexacosanamide |
|
 | | 7AP | | Name: | (1S,2S)-1-(2,4-DIAMINOPTERIDIN-6-YL)PROPANE-1,2-DIOL | | Formula: | C9 H12 N6 O2 | | SMILES: | n1c2c(ncc1C(O)C(O)C)nc(nc2N)N | | InChi: | InChI=1S/C9H12N6O2/c1-3(16)6(17)4-2-12-8-5(13-4)7(10)14-9(11)15-8/h2-3,6,16-17H,1H3,(H4,10,11,12,14,15)/t3-,6+/m0/s1 | | Synonyms: | 4-AMINOBIOPTERIN | | Definition date: | 2006-03-07 | | Last modified: | 2021-03-01 | | Identifier: | (1S,2S)-1-(2,4-diaminopteridin-6-yl)propane-1,2-diol |
|
 | | 7AX | | Name: | 7-(2-(2-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)ethoxy)phenoxy)-2-naphthonitrile | | Formula: | C23 H17 N3 O4 | | SMILES: | c2c1ccc(cc1cc(c2)Oc4ccccc4OCCN3C=CC(=O)NC3=O)C#N | | InChi: | InChI=1S/C23H17N3O4/c24-15-16-5-6-17-7-8-19(14-18(17)13-16)30-21-4-2-1-3-20(21)29-12-11-26-10-9-22(27)25-23(26)28/h1-10,13-14H,11-12H2,(H,25,27,28) | | Synonyms: | JLJ649 | | Definition date: | 2016-09-26 | | Last modified: | 2021-03-01 | | Release date: | 2017-01-11 | | Identifier: | 7-{2-[2-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)ethoxy]phenoxy}naphthalene-2-carbonitrile |
|
 | | LHP | | Name: | (3beta,5beta,9beta)-3-(propanoyloxy)cholan-24-oic acid | | Formula: | C27 H44 O4 | | SMILES: | O=C(O)CCC(C4C3(C(C2C(C1(CCC(OC(=O)CC)CC1CC2)C)CC3)CC4)C)C | | InChi: | InChI=1S/C27H44O4/c1-5-25(30)31-19-12-14-26(3)18(16-19)7-8-20-22-10-9-21(17(2)6-11-24(28)29)27(22,4)15-13-23(20)26/h17-23H,5-16H2,1-4H3,(H,28,29)/t17-,18-,19-,20+,21-,22+,23+,26+,27-/m1/s1 | | Synonyms: | Lithocholic acid propionate | | Definition date: | 2013-02-08 | | Last modified: | 2021-03-01 | | Release date: | 2013-06-26 | | Identifier: | (3beta,5beta,9beta)-3-(propanoyloxy)cholan-24-oic acid |
|
 | | LHZ | | Name: | (6~{R})-7-[[3,4-bis(fluoranyl)phenyl]methyl]-6-(methoxymethyl)-2-[5-methyl-2-[(2-methylpyrazol-3-yl)amino]pyrimidin-4-yl]-5,6-dihydroimidazo[1,2-a]pyrazin-8-one | | Formula: | C24 H24 F2 N8 O2 | | SMILES: | COC[CH]1Cn2cc(nc2C(=O)N1Cc3ccc(F)c(F)c3)c4nc(Nc5ccnn5C)ncc4C | | InChi: | InChI=1S/C24H24F2N8O2/c1-14-9-27-24(30-20-6-7-28-32(20)2)31-21(14)19-12-33-11-16(13-36-3)34(23(35)22(33)29-19)10-15-4-5-17(25)18(26)8-15/h4-9,12,16H,10-11,13H2,1-3H3,(H,27,30,31)/t16-/m1/s1 | | Synonyms: | AZD0364 | | Definition date: | 2019-08-19 | | Last modified: | 2021-03-01 | | Release date: | 2019-11-20 | | Identifier: | (6~{R})-7-[[3,4-bis(fluoranyl)phenyl]methyl]-6-(methoxymethyl)-2-[5-methyl-2-[(2-methylpyrazol-3-yl)amino]pyrimidin-4-yl]-5,6-dihydroimidazo[1,2-a]pyrazin-8-one |
|
 | | LI1 | | Name: | 1-[2,6,10.14-TETRAMETHYL-HEXADECAN-16-YL]-2-[2,10,14-TRIMETHYLHEXADECAN-16-YL]GLYCEROL | | Formula: | C42 H86 O3 | | SMILES: | OCC(OCCC(CCCC(CCCCCCCC(C)C)C)C)COCCC(C)CCCC(C)CCCC(C)CCCC(C)C | | InChi: | InChI=1S/C42H86O3/c1-35(2)19-13-11-10-12-14-21-37(5)23-17-28-41(9)30-32-45-42(33-43)34-44-31-29-40(8)27-18-26-39(7)25-16-24-38(6)22-15-20-36(3)4/h35-43H,10-34H2,1-9H3/t37-,38+,39?,40+,41-,42-/m1/s1 | | Synonyms: | LIPID FRAGMENT | | Definition date: | 1999-09-16 | | Last modified: | 2021-03-01 | | Identifier: | (2R)-3-{[(3S,7R,11S)-3,7,11,15-tetramethylhexadecyl]oxy}-2-{[(3R,7R)-3,7,15-trimethylhexadecyl]oxy}propan-1-ol |
|
 | | 7BD | | Name: | 3-[(9H-fluoren-9-ylideneamino)oxy]propanoic acid | | Formula: | C16 H13 N O3 | | SMILES: | O=C(O)CCON=C3c1ccccc1c2c3cccc2 | | InChi: | InChI=1S/C16H13NO3/c18-15(19)9-10-20-17-16-13-7-3-1-5-11(13)12-6-2-4-8-14(12)16/h1-8H,9-10H2,(H,18,19) | | Synonyms: | 3-(9H-fluoren-9-ylideneaminooxy)propanoic acid | | Definition date: | 2009-04-06 | | Last modified: | 2021-03-01 | | Identifier: | 3-[(9H-fluoren-9-ylideneamino)oxy]propanoic acid |
|
 | | 7BL | | Name: | (4S,5E,8S,9E,11S,13E,15E,18R)-4-hydroxy-8-methoxy-9,11-dimethyl-18-[(1Z,4E)-2-methylhexa-1,4-dien-1-yl]oxacyclooctadeca-5,9,13,15-tetraen-2-one | | Formula: | C27 H40 O4 | | SMILES: | CC=[C@H]CC(=C/C1CC=CC=CCC(C=C(C(OC)CC=CC(CC(O1)=O)O)C)C)C | | InChi: | InChI=1S/C27H40O4/c1-6-7-13-22(3)19-25-16-11-9-8-10-14-21(2)18-23(4)26(30-5)17-12-15-24(28)20-27(29)31-25/h6-12,15,18-19,21,24-26,28H,13-14,16-17,20H2,1-5H3/b7-6+,10-8+,11-9+,15-12+,22-19-,23-18+/t21-,24+,25+,26-/m0/s1 | | Synonyms: | biselyngbyolide B | | Definition date: | 2015-03-16 | | Last modified: | 2021-03-01 | | Release date: | 2016-01-13 | | Identifier: | (4S,5E,8S,9E,11S,13E,15E,18R)-4-hydroxy-8-methoxy-9,11-dimethyl-18-[(1Z,4E)-2-methylhexa-1,4-dien-1-yl]oxacyclooctadeca-5,9,13,15-tetraen-2-one |
|
 | | 7BS | | Name: | (4S,5E,8S,9E,11S,13E,15E,18R)-8-methoxy-9,11-dimethyl-18-[(1Z,4E)-2-methylhexa-1,4-dien-1-yl]-2-oxooxacyclooctadeca-5,9,13,15-tetraen-4-yl 3-O-methyl-beta-D-glucopyranoside | | Formula: | C34 H52 O9 | | SMILES: | COC2CC=CC(OC1OC(C(C(C1O)OC)O)CO)CC(OC(CC=CC=CCC(C=C2C)C)[C@H]=C(C)C[C@H]=CC)=O | | InChi: | InChI=1S/C34H52O9/c1-7-8-14-24(3)20-26-16-12-10-9-11-15-23(2)19-25(4)28(39-5)18-13-17-27(21-30(36)41-26)42-34-32(38)33(40-6)31(37)29(22-35)43-34/h7-13,17,19-20,23,26-29,31-35,37-38H,14-16,18,21-22H2,1-6H3/b8-7+,11-9+,12-10+,17-13+,24-20-,25-19+/t23-,26+,27+,28-,29+,31+,32+,33-,34+/m0/s1 | | Synonyms: | Biselyngbyaside | | Definition date: | 2015-02-27 | | Last modified: | 2021-03-01 | | Release date: | 2016-01-13 | | Identifier: | (4S,5E,8S,9E,11S,13E,15E,18R)-8-methoxy-9,11-dimethyl-18-[(1Z,4E)-2-methylhexa-1,4-dien-1-yl]-2-oxooxacyclooctadeca-5,9,13,15-tetraen-4-yl 3-O-methyl-beta-D-glucopyranoside |
|
 | | 7BT | | Name: | (~{Z})-~{N}-[2-[(2~{R},3~{R},4~{R},5~{R},6~{R})-6-(hydroxymethyl)-3,4,5-tris(oxidanyl)oxan-2-yl]ethyl]-3-(3,4,5-trimethoxyphenyl)prop-2-enamide | | Formula: | C20 H29 N O9 | | SMILES: | COc1cc(C=CC(=O)NCC[CH]2O[CH](CO)[CH](O)[CH](O)[CH]2O)cc(OC)c1OC | | InChi: | InChI=1S/C20H29NO9/c1-27-13-8-11(9-14(28-2)20(13)29-3)4-5-16(23)21-7-6-12-17(24)19(26)18(25)15(10-22)30-12/h4-5,8-9,12,15,17-19,22,24-26H,6-7,10H2,1-3H3,(H,21,23)/b5-4-/t12-,15-,17+,18+,19-/m1/s1 | | Synonyms: | Laura237 | | Definition date: | 2016-09-29 | | Last modified: | 2021-03-01 | | Release date: | 2017-05-31 | | Identifier: | (~{Z})-~{N}-[2-[(2~{R},3~{R},4~{R},5~{R},6~{R})-6-(hydroxymethyl)-3,4,5-tris(oxidanyl)oxan-2-yl]ethyl]-3-(3,4,5-trimethoxyphenyl)prop-2-enamide |
|
 | | LIH | | Name: | 6-([5-QUINOLYLAMINO]METHYL)-2,4-DIAMINO-5-METHYLPYRIDO[2,3-D]PYRIMIDINE | | Formula: | C18 H17 N7 | | SMILES: | n1cc(c(c2c1nc(nc2N)N)C)CNc4c3cccnc3ccc4 | | InChi: | InChI=1S/C18H17N7/c1-10-11(9-23-17-15(10)16(19)24-18(20)25-17)8-22-14-6-2-5-13-12(14)4-3-7-21-13/h2-7,9,22H,8H2,1H3,(H4,19,20,23,24,25) | | Synonyms: | SRI-9439 | | Definition date: | 2002-01-07 | | Last modified: | 2021-03-01 | | Identifier: | 5-methyl-6-[(quinolin-5-ylamino)methyl]pyrido[2,3-d]pyrimidine-2,4-diamine |
|
 | | LII | | Name: | (Z)-6-(2-[2,5-DIMETHOXYPHENYL]ETHEN-1-YL)-2,4-DIAMINO-5-METHYLPYRIDO[2,3-D]PYRIMIDINE | | Formula: | C18 H19 N5 O2 | | SMILES: | n1cc(c(c2c1nc(nc2N)N)C)/C=Cc3cc(OC)ccc3OC | | InChi: | InChI=1S/C18H19N5O2/c1-10-12(9-21-17-15(10)16(19)22-18(20)23-17)5-4-11-8-13(24-2)6-7-14(11)25-3/h4-9H,1-3H3,(H4,19,20,21,22,23)/b5-4- | | Synonyms: | SRI-9662 | | Definition date: | 2002-01-07 | | Last modified: | 2021-03-01 | | Identifier: | 6-[(Z)-2-(2,5-dimethoxyphenyl)ethenyl]-5-methylpyrido[2,3-d]pyrimidine-2,4-diamine |
|
 | | 7CA | | Name: | 5,7-DIHYDROXY-2-(4-METHOXYPHENYL)-8-(3-METHYLBUTYL)-4-OXO-4H-CHROMEN-3-YL 6-DEOXY-ALPHA-L-MANNOPYRANOSIDE | | Formula: | C27 H32 O10 | | SMILES: | O=C2C(OC1OC(C(O)C(O)C1O)C)=C(Oc3c(c(O)cc(O)c23)CCC(C)C)c4ccc(OC)cc4 | | InChi: | InChI=1S/C27H32O10/c1-12(2)5-10-16-17(28)11-18(29)19-21(31)26(37-27-23(33)22(32)20(30)13(3)35-27)24(36-25(16)19)14-6-8-15(34-4)9-7-14/h6-9,11-13,20,22-23,27-30,32-33H,5,10H2,1-4H3/t13-,20-,22+,23+,27-/m0/s1 | | Synonyms: | ICARISID II | | Definition date: | 2006-05-26 | | Last modified: | 2021-03-01 | | Identifier: | 5,7-dihydroxy-2-(4-methoxyphenyl)-8-(3-methylbutyl)-4-oxo-4H-chromen-3-yl 6-deoxy-alpha-L-mannopyranoside |
|
 | | 7CH | | Name: | (2S,4aR,6R,7R,7aS)-6-(4-amino-7H-pyrrolo[2,3-d]pyrimidin-7-yl)tetrahydro-4H-furo[3,2-d][1,3,2]dioxaphosphinine-2,7-diol 2-oxide | | Formula: | C11 H13 N4 O6 P | | SMILES: | O=P3(OCC4OC(n2c1ncnc(N)c1cc2)C(O)C4O3)O | | InChi: | InChI=1S/C11H13N4O6P/c12-9-5-1-2-15(10(5)14-4-13-9)11-7(16)8-6(20-11)3-19-22(17,18)21-8/h1-2,4,6-8,11,16H,3H2,(H,17,18)(H2,12,13,14)/t6-,7-,8-,11-/m1/s1 | | Synonyms: | 7-CH-cAMP | | Definition date: | 2013-12-16 | | Last modified: | 2021-03-01 | | Release date: | 2014-03-19 | | Identifier: | (2S,4aR,6R,7R,7aS)-6-(4-amino-7H-pyrrolo[2,3-d]pyrimidin-7-yl)tetrahydro-4H-furo[3,2-d][1,3,2]dioxaphosphinine-2,7-diol 2-oxide |
|
 | | 7CY | | Name: | (1R,2S,3R,5R)-3-(6-amino-9H-purin-9-yl)-5-(hydroxymethyl)cyclopentane-1,2-diol | | Formula: | C11 H15 N5 O3 | | SMILES: | n1cnc2c(c1N)ncn2C3C(O)C(C(C3)CO)O | | InChi: | InChI=1S/C11H15N5O3/c12-10-7-11(14-3-13-10)16(4-15-7)6-1-5(2-17)8(18)9(6)19/h3-6,8-9,17-19H,1-2H2,(H2,12,13,14)/t5-,6-,8-,9+/m1/s1 | | Synonyms: | Aristeromycin | | Definition date: | 2016-10-05 | | Last modified: | 2021-03-01 | | Release date: | 2016-10-19 | | Identifier: | (1R,2S,3R,5R)-3-(6-amino-9H-purin-9-yl)-5-(hydroxymethyl)cyclopentane-1,2-diol |
|
